Randomized, open-label, multicenter, phase III study of eribulin versus dacarbazine in patients (pts) with leiomyosarcoma (LMS) and adipocytic sarcoma (ADI).
暂无分享，去创建一个
J. Blay | G. Demetri | A. Italiano | R. Maki | A. Le Cesne | P. Hohenberger | H. Gelderblom | Shreyaskumar R Patel | S. Rha | S. Bauer | G. Grignani | B. Chmielowski | S. Chawla | D. D’Adamo | Benjamin Wang | V. Camargo